Freestone Capital Holdings »

Actuate Therapeutics shares owned by Freestone Capital Holdings

Quarter-by-quarter ownership of Actuate Therapeutics (ACTU) shares owned by Freestone Capital Holdings from 13F filings

Historical chart of Freestone Capital Holdings investment in Actuate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Actuate Therapeutics held by Freestone Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Actuate Therapeutics by Freestone Capital Holdings

Quarter filed Position value Share count Share price at filing
2025-09-30 $67k 10k 6.69
2025-06-30 $61k 10k 6.11
2025-03-31 $68k 10k 6.77
2024-12-31 $80k 10k 7.96

More positions owned by Freestone Capital Holdings

Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon Put Option (AMZN)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Meta Platforms Cl A (META)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Broadcom (AVGO)

View all positions for Freestone Capital Holdings

Top funds holding Actuate Therapeutics

BIOS Capital Management
Voss Capital
Vanguard Group
BlackRock
Geode Capital Management
Northern Trust
State Street Corporation
Northwestern Mutual Wealth Management Company
Gleason Group
SFMG Wealth Advisors
LPL Financial
Charles Schwab Investment Management
Wells Fargo & Company
Royal Bank of Canada
Freestone Capital Holdings

View all funds holding Actuate Therapeutics